To include your compound in the COVID-19 Resource Center, submit it here.

GP1BB identified as NASH target

DISEASE CATEGORY: Hepatic

INDICATION: Non-alcoholic steatohepatitis (NASH)

Mouse studies suggest inhibiting GP1BB could help treat

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE